Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On January 7, we reiterated our Neutral recommendation on Hudson City Bancorp, Inc. ( HCBK - Analyst Report ) based on its strong capital ratios and decline in interest expenses. However, the pressure on net interest income and net interest margin remained the headwinds.
Why the Neutral Stance?
Hudson City’s third-quarter revenues of $206.3 million as well as earnings per share of 12 cents missed the Zacks Consensus Estimates of $221 million and 14 cents, respectively. However, estimates for Hudson City – a bank holding company that provides retail banking services – have been stable over the last 30 days.
M&T has agreed to takeover Hudson City in a cash-and-stock deal worth $3.7 billion. The deal would combine Hudson City’s retail network with M&T’s full-service commercial banking suite and help expanding the premier community banking franchise in the eastern U.S.
Further, Hudson City was not required to participate in the aid provided by the government during the height of the financial crisis, and therefore it has no loans to pay off. Additionally, Hudson City Savings Bank – the company’s only subsidiary – maintains a healthy capital position.
On the flipside, though the restructuring initiatives taken by the company in the fourth quarter of 2011 boosted its net interest margin (NIM) by 42 basis points in the subsequent quarter, it has declined from that level in the recent past. Notably, in the second and third quarters of 2012, NIM has declined to 2.12% and 2.02%, respectively, from 2.15%.
We believe that the current low interest rate environment would compress the net interest margin further from its higher level, which resulted from the restructuring. Moreover, sluggish economic recovery and uncertainty surrounding the new and anticipated regulations are likely to serve as the headwinds.
Other Stocks to Consider
Other banking stocks that are currently performing well include Cardinal Financial Corp. ( CFNL - Snapshot Report ) and First Interstate Bancsystem Inc. ( FIBK - Snapshot Report ) . Both carry Zacks Rank #1 (Strong Buy).
Read the full Analyst Report on HCBK
Read the full Snapshot Report on FIBK
Read the full Snapshot Report on CFNL